Helmy Eltoukhy - Mar 18, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Stock symbol
GH
Transactions as of
Mar 18, 2024
Transactions value $
$0
Form type
4
Date filed
3/22/2024, 05:18 PM
Previous filing
Feb 13, 2024
Next filing
Apr 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Performance-Based Restricted Stock Units Other $0 -1.13M -100% $0.00* 0 Mar 18, 2024 Common Stock 1.13M Direct F1, F2, F3
transaction GH Restricted Stock Units Award $0 +45.8K $0.00 45.8K Mar 18, 2024 Common Stock 45.8K $0.00 Direct F4, F5
transaction GH Restricted Stock Units Award $0 +287K $0.00 287K Mar 18, 2024 Common Stock 287K $0.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 This performance stock unit award that was granted on May 26, 2020 was cancelled and forfeited effective as of March 18, 2024. This was for good and valuable consideration, including continued employment with the Company.
F3 One-third of the granted performance-based restricted stock units vested and converted into shares of common stock based on the Issuer's achievement of the stock price milestone, as certified by the Issuer's compensation committee on January 2, 2021.
F4 This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31/2024, 6/30/2024, 9/30/2024, and 12/31/2024.
F5 Not applicable for Restricted Stock Units.
F6 This restricted stock unit award will vest with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining 24 months.